Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 3 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Unresectable Colorectal Cancer 1 Triple Negative Breast Neoplasms 1 Sezary Syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Myeloid Malignancies 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Temozolomide 162 Radiosurgery 114 Radiotherapy 99 Bevacizumab 95 Magnetic Resonance Spectroscopy 64 Carboplatin 48 Etoposide 34 Surgical Procedures, Operative 33 Irinotecan 33 pembrolizumab 32 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 29 Carmustine 28 Cisplatin 25 Lomustine 24 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × magrolimab × Clear all

NCT05169944 2025-07-09

PNOC025

University of California, San Francisco

Phase 1 Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡